Published in Pigment Cell Res on October 01, 2003
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer (2009) 1.70
Antiviral, anti-parasitic, and cytotoxic effects of 5,6-dihydroxyindole (DHI), a reactive compound generated by phenoloxidase during insect immune response. Insect Biochem Mol Biol (2011) 0.98
Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J (2010) 0.91
Plumbagin Suppresses α-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells by Inhibiting Tyrosinase Activity. Int J Mol Sci (2017) 0.80
An Endogenous Electron Spin Resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application. PLoS One (2012) 0.79
Moisturizing different racial skin types. J Clin Aesthet Dermatol (2014) 0.79
MicroRNAs in melanoma development and resistance to target therapy. Oncotarget (2017) 0.78
Evaluation of melanogenesis in A-375 cells in the presence of DMSO and analysis of pyrolytic profile of isolated melanin. ScientificWorldJournal (2012) 0.77
Purification and characterization of melanogenic enzyme tyrosinase from button mushroom. Enzyme Res (2014) 0.77
Nano-scale morphology of melanosomes revealed by small-angle X-ray scattering. PLoS One (2014) 0.77
SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Med Genomics (2016) 0.76
STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body. J Biol Chem (2015) 0.76
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Exp Dermatol (2014) 0.75
Tyrosinase inhibition and antioxidant properties of Asphodelus microcarpus extracts. BMC Complement Altern Med (2016) 0.75
Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors. J Comput Aided Mol Des (2007) 0.75
Melanoma and the problem of malignancy. Tohoku J Exp Med (2004) 0.78